CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Overweg, K.
Right arrow Articles by Verheul, A. F. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Overweg, K.
Right arrow Articles by Verheul, A. F. M

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 1999, p. 444-444, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Streptococcus pneumoniae Flow-Cytometric Phagocytosis Assay


    LETTER
Top
Letter
References

In a recent article, Jansen and coworkers described the use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for the assessment of the phagocytic capacity of serotype-specific antibodies (1). This assay is an elegant and easy-to-perform flow-cytometric method, which allows the measuring of the phagocytic capacity of large numbers of pneumococcal vaccine antisera. The results look promising, as the interassay variation is low and the correlation with postvaccination immunoglobulin G concentrations is good.

In order to strengthen the potential of this method to exclusively identify anticapsular antibodies in vaccinated individuals, the authors have used hyperimmune rabbit antisera raised in our laboratory against a hydrophobic protein fraction of S. pneumoniae. These antisera did not recognize protein epitopes at the surface of heat-inactivated pneumococci that were grown to log phase on three consecutive days.

We regret that our antisera are poorly described in the article. This might lead to confusion. As a matter of clarification, we have raised hyperimmune rabbit sera against a fraction of surface-associated hydrophobic proteins that were extracted from different pneumococcal strains. Indirect immunocytometric analysis has confirmed that the sera recognize components exposed by encapsulated pneumococci. In addition, the in vitro phagocytic capacity of the sera was high with non-heat-inactivated pneumococci that were grown to log phase. Importantly, both antigenic surface exposure and phagocytic capacity of the sera were independent of the capsular type and the genotype of the pneumococcus (2).

The experiments described by Jansen and coworkers using the hyperimmune sera raised against the fraction of surface-associated hydrophobic pneumococcal proteins have been carried out independently in our laboratory. Heat inactivation was omitted for obvious reasons. In the experiments using non-heat-inactivated pneumococci that were grown to stationaryphase or to log phase on three consecutive days, the hyperimmune sera demonstrated phagocytic capacity (Fig. 1). Based on these observations, we conclude that the flow-cytometric phagocytosis assay described by Jansen and coworkers is also suitable for measuring antibodies that recognize protein epitopes exposed at the surface of encapsulated pneumococci.


View larger version (15K):
[in this window]
[in a new window]
 
FIG. 1.   The opsonic activity of preimmune (open symbols) and hyperimmune (closed symbols) rabbit sera raised against the surface-associated protein fraction of S. pneumoniae by using a pneumococcal clinical isolate grown to stationary phase (triangles) or to log phase (circles) on three consecutive days. In these experiments non-heat-inactivated bacteria were used.


    FOOTNOTES

* Phone: 31-10-408-8224

Fax: 31-10-408-9486

E-mail: hermans{at}kgk.fgg.eur.nl


    REFERENCES
Top
Letter
References

1. Jansen, W. T. M., J. Gootjes, M. Zelle, D. V. Madore, J. Verhoef, H. Snippe, and A. F. M. Verheul. 1998. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin. Diagn. Lab. Immunol. 5:703-710[Abstract/Free Full Text].
2. Overweg, K., R. de Groot, A. F. M. Verheul, A. Kerr, T. J. Mitchell, and P. W. M. Hermans. Opsonic antibodies directed against hydrophobic surface proteins of Streptococcus pneumoniae confer passive protection in mice. Unpublished data.
Karin Overweg
Ronald de Groot
Peter W. M. Hermans*
Department of Pediatrics
Erasmus University Medical
  Center Rotterdam
P.O. Box 1738
3000 DR Rotterdam
The Netherlands


    AUTHOR'S REPLY

The purpose of the described phagocytosis assay is to measure the phagocytic capacity of serotype-specific antibodies. Using highly encapsulated, heat-inactivated pneumococci, only anticapsular polysaccharide antibodies were able to promote phagocytosis. As we stated in Discussion, a potential disadvantage of the use of heat treatment is the potential denaturation of protein epitopes on the pneumococcus. Therefore, when the purpose is to evaluate the opsonic capacity of antipneumococcal protein antibodies, live and heat-inactivated strains should initially be compared.

We never intended to suggest that the described protein antisera of Overweg and coworkers were not able to promote phagocytosis of non-heat-inactivated strains. We agree that their protein antisera do promote phagocytosis of non-heat-inactivated bacteria and thereby may have protective capacities.

W. T. M. Jansen
H. Snippe
A. F. M Verheul
Eijkman-Winkler Institute for Microbiology,
  Infectious Diseases and Inflammation
Utrecht University Hospital
3584 CX Utrecht
The Netherlands


Clinical and Diagnostic Laboratory Immunology, May 1999, p. 444-444, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Overweg, K.
Right arrow Articles by Verheul, A. F. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Overweg, K.
Right arrow Articles by Verheul, A. F. M


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS